| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |